The effects of dexmedetomidine on regional cerebral blood flow and oxygen consumption during severe hemorrhagic hypotension in rats

Anesthesia and Analgesia

Volumn 113, Issue 2, 2011, Pages 349-355

  Chi, Oak Z ^a   Hunter, Christine ^a   Liu, Xia ^a   Weiss, Harvey R ^b  

^a ROBERT WOOD JOHNSON MEDICAL SCHOOL   (United States)

^b RUTGERS ROBERT WOOD JOHNSON MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DEXMEDETOMIDINE; HEMOGLOBIN; IODOPHENAZONE C 14; ISOFLURANE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERIAL OXYGEN SATURATION; ARTICLE; ARTIFICIAL VENTILATION; BLOOD ANALYSIS; BRAIN BLOOD FLOW; BRAIN CORTEX; CONTROLLED STUDY; CRYOMICROSPECTROPHOTOMETRY; DISEASE SEVERITY; DRUG EFFECT; HEART RATE; HEMOGLOBIN BLOOD LEVEL; HEMORRHAGIC HYPOTENSION; LUNG; MALE; MEAN ARTERIAL PRESSURE; MICROSPECTROPHOTOMETRY; NONHUMAN; OXYGEN CONSUMPTION; PRIORITY JOURNAL; RAT; VASCULAR RESISTANCE;

EID: 79961026030     PISSN: 00032999     EISSN: None     Source Type: Journal    
DOI: 10.1213/ANE.0b013e31822071db     Document Type: Article

References (21)

1. Drummond JC, Dao AV, Roth DM, Cheng CR, Atwater BI, Minokadeh A, Pasco LC, Patel PM. Effect of dexmedetomidine on cerebral blood flow velocity, cerebral metabolic rate, and carbon dioxide response in normal humans. Anesthesiology 2008;108:225-32 (Pubitemid 351156732)
2. Zornow MH, Fleischer JE, Scheller MS, Nakakimura K, Drummond JC. Dexmedetomidine, an2-adrenergic agonist, decreases cerebral blood flow in the isoflurane-anesthetized dog. Anesth Analg 1990;70:624-30 (Pubitemid 20384196)
3. Karlsson BR, Forsman M, Roald OK, Heier MS, Steen PA. Effect of dexmedetomidine, a selective and potent 2-agonist, on cerebral blood flow and oxygen consumption during halothane anesthesia in dogs. Anesth Analg 1990;71:125-9
4. Zhu N, Weiss HR. Oxy- and carboxyhemoglobin saturation in frozen small vessels. Am J Physiol 1991;260:H626-31
5. Chen S, Zhu X, Wang Q, Li W, Cheng D, Lei C, Xiong L. The early effect of Voluven, a novel hydroxyethyl starch (130/0.4), on cerebral oxygen supply and consumption in resuscitation of rabbit with acute hemorrhagic shock. J Trauma 2009;66:676-82
6. Torella F, McCollum CN. Regional haemoglobin oxygen saturation during surgical haemorrhage. Minerva Med 2004; 95:461-7 (Pubitemid 39481904)
7. Fale A, Kirsch JR, McPherson RW.2-Adrenergic agonist effects on normocapnic and hypercapnic cerebral blood flow in the dog are anesthetic dependent. Anesth Analg 1994;79:892-8 (Pubitemid 24324667)
8. Sakurada O, Kennedy C, Brown JD, Carbin OL, Sokoloff L. Measurement of local cerebral blood flow with iodo-C14- antipyrine. Am J Physiol 1978;234:H59-66 (Pubitemid 9174482)
9. Nakai K, Itakura T, Naka Y, Nakakita K, Kamei I, Imai H, Yokote H, Komai N. The distribution of adrenergic receptors in cerebral blood vessels: An autoradiographic study. Brain Res 1986;381:148-52 (Pubitemid 16049671)
10. Willems EW, Valdivia LF, Villalón CM, Saxena PR. Possible role of κ-adrenoceptor subtypes in acute migraine therapy. Cephalalgia 2003;23:245-57 (Pubitemid 36577941)
11. Asano Y, Koehler RC, Kawaguchi T, McPherson RW. Pial arteriolar constriction to alpha 2-adrenergic agonist dexmedetomidine in the rat. Am J Physiol 1997;272:H2547-56
12. Globus MY, Busto R, Dietrich WD, Martinez E, Valdes I, Ginsberg MD. Direct evidence for acute and massive norepinephrine release in the hippocampus during transient ischemia. J Cereb Blood Flow Metab 1989;9:892-6 (Pubitemid 20006909)
13. Matsumoto M, Zornow MH, Rabin BC, Maze M. The alpha 2-adrenergic agonist, dexmedetomidine, selectively attenuates ischemia-induced increases in striatal norepinephrine concentrations. Brain Res 1993;627:325-9 (Pubitemid 23313271)
14. Englelhard K, Werner C, Kaspar S, Möllenberg O, Blobner M, Bachl M, Kochs E. Effect of the alpha2-agonist dexmedetomidine on cerebral neurotransmitter concentrations during cerebral ischemia in rats. Anesthesiology 2002;96:450-7 (Pubitemid 34121758)
15. Dolphin AC. Noradrenergic modulation of glutamate release in the cerebellum. Brain Res 1982;252:111-6 (Pubitemid 13231469)
16. Talke P, Bickler PE. Effects of dexmedetomidine on hypoxiaevoked glutamate release and glutamate receptor activity in hippocampal slices. Anesthesiology 1996;85:551-7 (Pubitemid 26332608)
17. Bryan RM Jr., Eichler MY, Swafford MW, Johnson TD, Suresh MS, Childres WF. Stimulation of alpha 2 adrenoceptors dilates the rat middle cerebral artery. Anesthesiology 1996;85:82-90 (Pubitemid 26234698)
18. Maier C, Steinberg GK, Sun GH, Zhi GT, Maze M. Neuroprotection by the2-adrenoreceptor agonist dexmedetomidine in a focal model of cerebral ischemia. Anesthesiology 1993; 79:306-12 (Pubitemid 23224843)
19. Kuhmonen J, Pokorný J, Miettinen R, Haapalinna A, Jolkkonen J, Riekkinen P Sr, Sivenius J. Neuroprotective effects of dexmedetomidine in the gerbil hippocampus after transient global ischemia. Anesthesiology 1997;87:371-7 (Pubitemid 27435380)
20. Halonen T, Kotti T, Tuunanen J, Toppinen A, Miettinen R, Riekkinen PJ.2-Adrenoceptor agonist, dexmedetomidine, protects against kainic acid-induced convulsions and neuronal damage. Brain Res 1995;693:217-24
21. Nakano T, Okamoto H. Dexmedetomidine-induced cerebral hypoperfusion exacerbates ischemic brain injury in rats. J Anesth 2009;23:378-84